Related Articles
The influence of testosterone suppression on HER2 immunoexpression in prostatic neoplastic tissue
Androgen deprivation therapy affects BCL-2 expression in human prostate cancer
Cancer‑related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction Corrigendum in /10.3892/ijmm.2020.4546
Conversion to monotherapy with luteinizing‑hormone releasing hormone agonist or orchiectomy after reaching PSA nadir following maximal androgen blockade is able to prolong progression‑free survival in patients with metastatic prostate cancer: A propensity score matching analysis
Palmitoylome profiling indicates that androgens regulate the palmitoylation of α‑tubulin in prostate cancer‑derived LNCaP cells and supernatants